News & Stories

In a groundbreaking initiative, The Hong Kong University of Science and Technology (HKUST) has unveiled four AI-driven models poised to transform the medical and healthcare fields. These AI models can assist both general and specialist medical practitioners in diagnosing and prognosing up to 30 types of cancers and diseases, with some achieving accuracy comparable to that of medical experts with five years of experience or more.

The Hong Kong University of Science and Technology (HKUST) signed a memorandum of understanding (MoU) with Alibaba Group (Alibaba) today, outlying their plans to establish the “HKUST-Alibaba Joint Laboratory on Big Data and Artificial Intelligence”, with an aim to fostering forward-looking research in emerging technologies including generative AI and big data. Signing the MoU on campus today were Prof. Tim CHENG, HKUST Vice-President (Research & Development) and WU Zeming, Chief Technology Officer of Alibaba Group. Under the agreement, Alibaba and HKUST plan to jointly establish the lab over the next three years, researching on frontier areas including AI, data science, language models, multimodal training and inference, computational infrastructure and system software. The joint lab and its research projects will be managed, coordinated and planned by committees formed by experts from both parties.

The project will enable industry stakeholders to better gauge near-term tourism outlook for pre-emptive policy and business planning.

The platform will greatly facilitate marine research work and offer valuable data to policy makers

Patrick TU (right) and other cofounders of Dayta AI navigated through failures and challenges with resilience and determination. Resilience is a survival trait for start-up entrepreneurs. Patrick TU and his teammates, all aged 26, knows well how to hustle out of setbacks, one after another, in their four-year entrepreneurship journey. Every failure points a new direction – that’s the belief that helps them bounce back and eventually build a start-up recognized by Forbes’ 30 Under 30. 

Don and Kelvin co-founded AQUMON in 2015 with the vision of democratizing financial services. In 2015, when Dr. Don HUANG was still teaching financial engineering at HKUST, he received a call from his former bank colleague Kelvin LEI, asking whether he would be interested in starting a business with him. The answer was an instant “Yes!” “Kelvin told me his vision of democratizing wealth management so that more people could enjoy better services. It wasn’t easy for the algorithms and financial modeling involved, but I immediately felt it was a great opportunity,” says the HKUST alumnus. 

In a new study, scientists at The Hong Kong University of Science and Technology (HKUST) have revealed that most T cell epitopes known to be targeted upon natural infection are seemingly unaffected by current SARS-CoV-2 variants. In their latest research, the team compiled and analysed data from 18 immunological studies of T cell responses involving over 850 recovered COVID-19 patients from across four continents who are well-distributed in age, gender, disease severity and blood collection time. They demonstrated that T cells in these patients targeted fragments (epitopes) of almost all of the virus' proteins, including the spike protein that is a main target of many existing vaccines. As an important finding, based on analysis of over 850,000 SARS-CoV-2 genetic sequences from around the world, most of these epitopes appeared to be unaffected by the current variants of concern.